Business Description
Precision BioSciences is a US-based medical research company focused on developing treatments that work by editing the DNA inside living patients. Founded in 2006 and based in Durham, North Carolina, the company has built its own gene editing technology, called ARCUS, which it uses to target and modify specific sections of genetic material. Its current pipeline includes experimental treatments for chronic hepatitis B, Duchenne muscular dystrophy, a rare mitochondrial condition, and an inherited liver disorder, with additional work underway through partnerships with other biotechnology firms.
